Physician profile
Steven E Davis
NPI 1154300978
$676.77
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $73.95 · 2021: $225 · 2022: $203 · 2023: $134 · 2024: $40.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.97 | 2020-2022 | |
| Lilly USA, LLC | $125.16 | 2022-2023 | Jardiance, Emgality, Mounjaro |
| Abbott Laboratories | $85.22 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amarin Pharma, INC. | $74.12 | 2021 | |
| Covidien Lp | $32.56 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $28.83 | 2022 | |
| Glaxosmithkline, LLC. | $23.57 | 2023 | Shingrix, Arexvy |
| Xeris Pharmaceuticals, INC. | $21.35 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.50 | 2021 | |
| Medtronic, INC. | $20.04 | 2021 | |
| Tactile Systems Technology INC | $17.93 | 2022 | |
| Pfizer INC. | $15.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.